630 related articles for article (PubMed ID: 17669103)
21. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
[TBL] [Abstract][Full Text] [Related]
22. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
23. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
Madisch A; Miehlke S; Neuber F; Morgner A; Kuhlisch E; Rappel S; Lehn N; Bayerdörffer E; Seitz G; Stolte M
Aliment Pharmacol Ther; 2006 Feb; 23(4):473-9. PubMed ID: 16441467
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
[TBL] [Abstract][Full Text] [Related]
25. Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Ishizaki T; Hishida A
Helicobacter; 2007 Aug; 12(4):317-23. PubMed ID: 17669104
[TBL] [Abstract][Full Text] [Related]
26. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test.
Magen E; Mishal J; Schlesinger M; Scharf S
Helicobacter; 2007 Oct; 12(5):567-71. PubMed ID: 17760727
[TBL] [Abstract][Full Text] [Related]
27. Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.
Seddik H; Boutallaka H; Elkoti I; Nejjari F; Berraida R; Berrag S; Loubaris K; Sentissi S; Benkirane A
Eur J Clin Pharmacol; 2019 May; 75(5):639-645. PubMed ID: 30694338
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study.
Cheon JH; Kim JH; Lee SK; Kim TI; Kim WH; Lee YC
Helicobacter; 2008 Dec; 13(6):564-71. PubMed ID: 19166423
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.
Chuang CH; Sheu BS; Kao AW; Cheng HC; Huang AH; Yang HB; Wu JJ
Hepatogastroenterology; 2007; 54(73):320-4. PubMed ID: 17419283
[TBL] [Abstract][Full Text] [Related]
30. [Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children].
Zhao HM; Ou-Yang HJ; Duan BP; Xu B; Chen ZY; Tang J; You JY
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Mar; 16(3):230-3. PubMed ID: 24661511
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on?
Qua CS; Manikam J; Goh KL
J Dig Dis; 2010 Aug; 11(4):244-8. PubMed ID: 20649738
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate?
Sezikli M; Cetinkaya ZA; Sezikli H; Güzelbulut F; Tiftikçi A; Ince AT; Gökden Y; Yaşar B; Atalay S; Kurdaş OO
Helicobacter; 2009 Aug; 14(4):280-5. PubMed ID: 19674132
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
Ott EA; Mazzoleni LE; Edelweiss MI; Sander GB; Wortmann AC; Theil AL; Somm G; Cartell A; Rivero LF; Uchôa DM; Francesconi CF; Prolla JC
Aliment Pharmacol Ther; 2005 May; 21(10):1231-9. PubMed ID: 15882244
[TBL] [Abstract][Full Text] [Related]
35. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].
Bravo MV; Bunout D; Leiva L; de la Maza MP; Barrera G; de la Maza J; Hirsch S
Rev Med Chil; 2008 Aug; 136(8):981-8. PubMed ID: 18949181
[TBL] [Abstract][Full Text] [Related]
36. Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.
Cadranel S; Bontemps P; Van Biervliet S; Alliet P; Lauvau D; Vandenhoven G; Vandenplas Y
Acta Paediatr; 2007 Jan; 96(1):82-6. PubMed ID: 17187610
[TBL] [Abstract][Full Text] [Related]
37. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
[TBL] [Abstract][Full Text] [Related]
38. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
Katsinelos P; Tziomalos K; Chatzimavroudis G; Vasiliadis T; Katsinelos T; Pilpilidis I; Triantafillidis I; Paroutoglou G; Papaziogas B
Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
[TBL] [Abstract][Full Text] [Related]
39. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
[TBL] [Abstract][Full Text] [Related]
40. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
Tan HJ; Rizal AM; Rosmadi MY; Goh KL
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
